Answers are grounded in this paper and cite their sources.
Objective: To describe high-performance liquid chromatography (HPLC) classifications and compare the sickling test with recorded sickle-cell status in a referred hospital population in Central India. Methods: In this retrospective cross-sectional study, 158 screening records from a three-month interval were assessed; 100 consecutive eligible records were analyzed. Cation-exchange HPLC used the Bio-Rad VARIANT II system. Sickle cell trait (SCT), sickle cell anemia/disease (SCA/SCD) and combined sickle-beta-thalassemia labels formed the presumptive comparator. Rank tests, Dunn-Holm post hoc comparisons, exact odds-ratio confidence intervals and transfusion-restricted analyses were performed. Results: Recorded categories included SCT (32%), SCA/SCD (29%) and sickle-beta-thalassemia (15%). Total hemoglobin was higher in SCT than SCA/SCD and mixed thalassemia (Holm-adjusted p=0.001 and p=0.011); transfusion frequency was lower (p=0.017 and p=0.003). Sickling-test sensitivity was 96.1%, specificity 62.5% and accuracy 88.0% relative to the comparator. In 66 participants without recorded recent transfusion, estimates were 96.1%, 53.3% and 86.4%, respectively. Family history was associated with comparator status (odds ratio 11.96; exact 95% confidence interval 1.71-511.28; p=0.003). Conclusion: HPLC supplied quantitative information beyond a binary sickling result. Recorded labels remain presumptive because transfusions, co-elution and unavailable independent confirmation constrain genotype interpretation. Screening should integrate clinical and transfusion review with confirmation of ambiguous patterns.
No takes yet. Share an insight, caveat, or question.
Malviya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: